<DOC>
	<DOCNO>NCT02021760</DOCNO>
	<brief_summary>- Trial objective : To test hypothesis remote per-postconditioning connection primary PCI reduce myocardial infarct size patient STEMI . - Trial Design : Placebo control randomize study parallel group - Primary Endpoint : Myocardial infarct size express percentage myocardium risk determine Cardiac Magnetic Resonance ( CMR ) day 4-7 - Efficacy Parameters : Myocardial infarct size express percentage myocardium risk determine CMR 6 month . - Global leave ventricular function determine leave ventricular ejection fraction determine CMR . - Microvascular obstruction determine CMR day 4-7 . Quantified ECV ( extracellular volume ) leave ventricular myocardium risk day 4-7 remodelling parameter day 180 . - Safety Parameters : Major adverse cardiovascular event .</brief_summary>
	<brief_title>Reduction Infarct Size Remote Per-postconditioning Patients With ST-elevation Myocardial Infarction</brief_title>
	<detailed_description>See . 3 patient leave include .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Patient plan primary PCI . Chest pain indicate myocardial ischemia duration &gt; 30 minute &lt; 6 hour prior randomization . ST elevation &gt; 0.1 mV ( &gt; 0.2 mV V2V3 ) &gt; two contiguous lead V1V6 . Informed consent . Previous myocardial infarction base medical history Qwave ECG area Left Bundle Branch Block ECG . Previous CABG Cardiac arrest Any contraindication CMR . Clinical symptom claudication Treatment glibenclamide cyclosporine admission . Any condition may interfere possibility patient comply complete study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>